Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Filings indexed 364 across all filing types
Latest filing 2026-02-26 Capital/Financing Update
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
[기재정정]타법인주식및출자증권취득결정
Capital/Financing Update Classification · 98% confidence The document is a regulatory filing titled '타법인주식및출자증권취득결정' (Decision to Acquire Shares and Securities of Another Corporation) and is explicitly marked as a '정정신고(보고)' (Correction Report). It details the acquisition of shares in '엔지더블유', including the acquisition price, purpose, and the updated schedule. This type of disclosure regarding corporate investment and capital allocation is classified as a Regulatory Filing (RNS) in our system, as it is a standard corporate announcement filed with regulatory authorities.
2026-02-26 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 98% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the bond, including interest rates, conversion prices, and the purpose of the funds. It is a regulatory filing submitted to the Financial Services Commission/Korea Exchange. Since it involves the issuance of new securities (convertible bonds), it falls under the 'Share Issue/Capital Change' category, which covers capital structure changes including convertible debt issuance.
2026-02-04 Korean
증권발행결과(자율공시)
Capital/Financing Update Classification · 100% confidence The document is a formal disclosure titled '증권 발행결과' (Securities Issuance Result) regarding the issuance of convertible bonds (제15회차 무기명식 이권부 무보증 사모 전환사채). It details the issuance method, amounts, and payment status. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2026-02-03 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a '주요사항보고서(전환사채권 발행결정) 정정신고' (Report on Material Matters: Decision to Issue Convertible Bonds - Amendment). It details the terms of a convertible bond issuance, including conversion price adjustments, interest rates, and the purpose of the funds. This falls under the category of capital and financing updates as it relates to the company's capital structure and debt financing activities.
2026-01-30 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service and Korea Exchange, specifically detailing the decision to issue convertible bonds (전환사채권 발행결정). This type of filing is a regulatory requirement for public companies in Korea to disclose significant capital structure changes, such as debt financing through convertible instruments. It fits the 'Capital/Financing Update' category as it details the terms, interest rates, conversion rights, and use of proceeds for a new financing activity.
2026-01-27 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the decision to issue convertible bonds (전환사채권 발행결정). It details the terms of the issuance, including interest rates, conversion prices, and the purpose of the funds. This falls under the category of capital and financing updates.
2026-01-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.